Connecting Myokines and Metabolism

다국어 초록 (Multilingual Abstract)

Skeletal muscle is the largest organ of the body in non-obese individuals and is now considered to be an endocrine organ. Hormones (myokines) secreted by skeletal muscle mediate communications between muscle and liver, adipose tissue, brain, and other organs. Myokines affect muscle mass and myofiber switching, and have profound effects on glucose and lipid metabolism and inflammation, thus contributing to energy homeostasis and the pathogenesis of obesity, diabetes, and other diseases. In this review, we summarize recent findings on the biology of myokines and provide an assessment of their potential as therapeutic targets.

참고문헌 (Reference)

1 Giri JG, "Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15" 13 : 2822-2830, 1994

2 Church TS, "Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity" 6 : e19657-, 2011

3 Kelly DP, "Transcriptional regulatory circuits controlling mitochondrial biogenesis and function" 18 : 357-368, 2004

4 Keller C, "Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content" 15 : 2748-2750, 2001

5 Norheim F, "The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans" 281 : 739-749, 2014

6 Akpan I, "The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity" 33 : 1265-1273, 2009

7 Stitt TN, "The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors" 14 : 395-403, 2004

8 Wullschleger S, "TOR signaling in growth and metabolism" 124 : 471-484, 2006

9 Pistilli EE, "Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats" 373 : 20-24, 2008

10 McPherron AC, "Suppression of body fat accumulation in myostatin-deficient mice" 109 : 595-601, 2002

11 Derynck R, "Smads: transcriptional activators of TGF-beta responses" 95 : 737-740, 1998

12 Janssen I, "Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr" 89 : 81-88, 2000

13 Al-Khalili L, "Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle" 20 : 3364-3375, 2006

14 Egerman MA, "Signaling pathways controlling skeletal muscle mass" 49 : 59-68, 2014

15 Garofalo RS, "Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta" 112 : 197-208, 2003

16 Pedersen BK, "Searching for the exercise factor: is IL-6 a candidate?" 24 : 113-119, 2003

17 Lu CW, "Sarcopenic obesity is closely associated with metabolic syndrome" 7 : e301-e307, 2013

18 Srikanthan P, "Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III" 5 : e10805-, 2010

19 Han K, "Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010" 9 : e86902-, 2014

20 Di Renzo L, "Role of interleukin-15 receptor alpha polymorphisms in normal weight obese syndrome" 22 : 105-113, 2009

21 Workeneh BT, "Review of muscle wasting associated with chronic kidney disease" 91 : 1128S-1132S, 2010

22 Platat C, "Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents" 49 : 2078-2085, 2006

23 McPherron AC, "Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member" 387 : 83-90, 1997

24 Lee SJ, "Regulation of myostatin activity and muscle growth" 98 : 9306-9311, 2001

25 Tuomilehto J, "Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance" 344 : 1343-1350, 2001

26 Colbert LH, "Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study" 52 : 1098-1104, 2004

27 Hamer M, "Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study" 126 : 928-933, 2012

28 Monninkhof EM, "Physical activity and breast cancer: a systematic review" 18 : 137-157, 2007

29 Padhi D, "Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer" 99 : E1967-E1975, 2014

30 Handschin C, "Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism" 27 : 728-735, 2006

31 Quinn LS, "Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders" 280 : 55-63, 2002

32 Di Renzo L, "Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C-->T genes in the relationship between body composition and resting metabolic rate" 10 : 235-245, 2006

33 Zhu X, "Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism" 26 : 262-272, 2004

34 Trendelenburg AU, "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size" 296 : C1258-C1270, 2009

35 Schuelke M, "Myostatin mutation associated with gross muscle hypertrophy in a child" 350 : 2682-2688, 2004

36 Lin J, "Myostatin knockout in mice increases myogenesis and decreases adipogenesis" 291 : 701-706, 2002

37 Shan T, "Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle" 27 : 1981-1989, 2013

38 Guo T, "Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity" 4 : e4937-, 2009

39 Yang W, "Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1" 282 : 3799-3808, 2007

40 Forbes D, "Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism" 206 : 264-272, 2006

41 Rodriguez J, "Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways" 71 : 4361-4371, 2014

42 Kambadur R, "Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle" 7 : 910-916, 1997

43 Pedersen BK, "Muscles, exercise and obesity: skeletal muscle as a secretory organ" 8 : 457-465, 2012

44 O’Connell G, "Muscle-specific deletion of exons 2 and 3 of the IL15RA gene in mice: effects on contractile properties of fast and slow muscles" 118 : 437-448, 2015

45 Johns N, "Muscle wasting in cancer" 45 : 2215-2229, 2013

46 Pedersen BK, "Muscle as an endocrine organ: focus on muscle-derived interleukin-6" 88 : 1379-1406, 2008

47 Schiaffino S, "Mechanisms regulating skeletal muscle growth and atrophy" 280 : 4294-4314, 2013

48 Moon SS, "Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010" 61 : 61-70, 2014

49 Pistilli EE, "Loss of IL-15 receptor alpha alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles" 121 : 3120-3132, 2011

50 Henningsen J, "Kratchmarova I. Dynamics of the skeletal muscle secretome during myoblast differentiation" 9 : 2482-2496, 2010

51 Albrecht E, "Irisin: a myth rather than an exercise-inducible myokine" 5 : 8889-, 2015

52 Moreno-Navarrete JM, "Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance" 98 : E769-E778, 2013

53 Huh JY, "Irisin in response to exercise in humans with and without metabolic syndrome" 100 : E453-E457, 2015

54 Erickson HP, "Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor?" 2 : 289-293, 2013

55 van Hall G, "Interleukin-6 stimulates lipolysis and fat oxidation in humans" 88 : 3005-3010, 2003

56 Carey AL, "Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase" 55 : 2688-2697, 2006

57 Quinn LS, "Interleukin-15: a novel anabolic cytokine for skeletal muscle" 136 : 3669-3672, 1995

58 Furmanczyk PS, "Interleukin-15 increases myosin accretion in human skeletal myogenic cultures" 27 : 845-851, 2003

59 O’Connell GC, "Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a mechanism that requires interleukin-15 receptor alpha" 458 : 614-619, 2015

60 Pistilli EE, "Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome" 43 : 45-53, 2008

61 Kimball SR, "Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle" 99 : 237S-242S, 2014

62 Zhang C, "Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice" 55 : 183-193, 2012

63 Hittel DS, "Increased secretion and expression of myostatin in skeletal muscle from extremely obese women" 58 : 30-38, 2009

64 Choi SJ, "Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice" 300 : E1031-E1037, 2011

65 Giri JG, "Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor" 14 : 3654-3663, 1995

66 Wolsk E, "IL-6 selectively stimulates fat metabolism in human skeletal muscle" 299 : E832-E840, 2010

67 Steensberg A, "IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans" 285 : E433-E437, 2003

68 He Y, "IL-15 receptor deletion results in circadian changes of locomotor and metabolic activity" 41 : 315-321, 2010

69 Goldstein MS, "Humoral nature of the hypoglycemic factor of muscular work" 10 : 232-234, 1961

70 Chen WS, "Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene" 15 : 2203-2208, 2001

71 Schakman O, "Glucocorticoid-induced skeletal muscle atrophy" 45 : 2163-2172, 2013

72 Sandri M, "Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy" 117 : 399-412, 2004

73 Turner N, "Fatty acid metabolism, energy expenditure and insulin resistance in muscle" 220 : T61-T79, 2014

74 Huh JY, "FNDC5 and irisin in humans: I. predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise" 61 : 1725-1738, 2012

75 Allen DL, "Expression and function of myostatin in obesity, diabetes, and exercise adaptation" 43 : 1828-1835, 2011

76 Friedrichsen M, "Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity" 366 : 204-214, 2013

77 Egan B, "Exercise metabolism and the molecular regulation of skeletal muscle adaptation" 17 : 162-184, 2013

78 Ostrowski K, "Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running" 508 (508): 949-953, 1998

79 Raschke S, "Evidence against a beneficial effect of irisin in humans" 8 : e73680-, 2013

80 Wu X, "Essential role of interleukin-15 receptor in normal anxiety behavior" 24 : 1340-1346, 2010

81 Fischer CP, "Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle" 287 : E1189-E1194, 2004

82 Keller C, "Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle" 99 : 2075-2079, 2005

83 Irving BA, "Effect of exercise training intensity on abdominal visceral fat and body composition" 40 : 1863-1872, 2008

84 Irwin ML, "Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial" 289 : 323-330, 2003

85 Amirouche A, "Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle" 150 : 286-294, 2009

86 Bodine SC, "Disuse-induced muscle wasting" 45 : 2200-2208, 2013

87 Bruce CR, "Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha" 287 : E616-E621, 2004

88 Bartoccioni E, "Constitutive and cytokine-induced production of interleukin-6 by human myoblasts" 42 : 135-138, 1994

89 Bortoluzzi S, "Computational reconstruction of the human skeletal muscle secretome" 62 : 776-792, 2006

90 Grabstein KH, "Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor" 264 : 965-968, 1994

91 Rodgers BD, "Clinical, agricultural, and evolutionary biology of myostatin: a comparative review" 29 : 513-534, 2008

92 Nocon M, "Association of physical activity with all-cause and cardiovascular mortality : a systematic review and meta-analysis" 15 : 239-246, 2008

93 Riechman SE, "Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses" 97 : 2214-2219, 2004

94 Nielsen AR, "Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass" 93 : 4486-4493, 2008

95 Goncalves MD, "Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition" 5 : e12707-, 2010

96 Baar K, "Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1" 16 : 1879-1886, 2002

97 Steensberg A, "Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans" 548 (548): 631-638, 2003

98 Attie KM, "A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers" 47 : 416-423, 2013

99 Manson JE, "A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women" 341 : 650-658, 1999

100 Koncarevic A, "A novel therapeutic approach to treating obesity through modulation of TGFbeta signaling" 153 : 3133-3146, 2012

101 Clop A, "A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep" 38 : 813-818, 2006

102 Szabo G, "A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice" 9 : 671-672, 1998

103 Grobet L, "A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle" 17 : 71-74, 1997

104 Bostrom P, "A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis" 481 : 463-468, 2012